PDZ and LIM Domain 3 (PDLIM3) (N-Term) Peptide
PDLIM3
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN981545
Quick Overview for PDZ and LIM Domain 3 (PDLIM3) (N-Term) Peptide (ABIN981545)
Target
PDLIM3
(PDZ and LIM Domain 3 (PDLIM3))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- N-Term
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-PDLIM3 antibody (Catalog #: ARP55067_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- PDLIM3 (PDZ and LIM Domain 3 (PDLIM3))
-
Background
-
PDLIM3 contains a PDZ domain and a LIM domain, indicating that it may be involved in cytoskeletal assembly. In support of this, PDLIM3 has been shown to bind the spectrin-like repeats of alpha-actinin-2 and to colocalize with alpha-actinin-2 at the Z lines of skeletal muscle.
Alias Symbols: ALP, DKFZp686L0362
Protein Interaction Partner: ABCA1
Protein Size: 364 -
Molecular Weight
- 39 kDa
-
Gene ID
- 27295
-
NCBI Accession
- NM_014476, NP_055291
-
UniProt
- Q53GG5
Target
-
You are here:
